MACKENZIE FINANCIAL CORP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$237,237
+11.9%
4,925
-2.6%
0.00%
Q1 2023$212,066
+6.0%
5,054
-3.7%
0.00%
Q4 2022$200,121
-5.6%
5,247
-3.1%
0.00%
Q3 2022$212,000
-87.0%
5,416
-89.0%
0.00%
-100.0%
Q1 2022$1,627,000
-23.9%
49,146
-2.2%
0.00%
-33.3%
Q4 2021$2,137,000
-1.5%
50,246
+2.7%
0.00%0.0%
Q3 2021$2,169,000
-3.5%
48,946
+23.8%
0.00%0.0%
Q2 2021$2,247,000
+29.7%
39,546
+70.9%
0.00%0.0%
Q1 2021$1,732,000
+179.8%
23,146
+170.0%
0.00%
+50.0%
Q4 2019$619,000
-48.5%
8,573
+0.1%
0.00%
-33.3%
Q3 2019$1,202,000
-22.7%
8,565
+0.8%
0.00%
-25.0%
Q2 2019$1,555,000
+50.5%
8,494
+30.7%
0.00%
+100.0%
Q1 2019$1,033,000
+289.8%
6,497
+135.1%
0.00%
+100.0%
Q4 2018$265,000
-89.1%
2,763
-83.9%
0.00%
-83.3%
Q3 2018$2,426,000
-1.2%
17,175
+9.5%
0.01%0.0%
Q2 2018$2,456,000
+622.4%
15,689
+642.5%
0.01%
+500.0%
Q1 2018$340,0002,1130.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders